Hopewell Therapeutics
Qiaobing Xu is the founder and interim CEO of Hopewell Therapeutics. Qiaobing received their PhD in chemical engineering from MIT in 2007 and was a postdoctoral researcher there from 2007 to 2010. Her research focuses on the development of new materials for use in fuel cells and batteries.
Qiaobing Xu received their PhD in Chemistry from Harvard University.
A direct report to Qiaobing Xu is and Thomas Hennessey Jr. - COO.
Hopewell Therapeutics
1 followers
Hopewell Therapeutics Inc. is a leading provider of cutting-edge technologies and services, offering novel drug delivery solutions in the form of lipid-based nanoparticles.